(ICHR) Ichor Holdings - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: KYG4740B1059

Gas Delivery Systems, Chemical Delivery Systems, Precision Components, Weldments, Surface Treatment

ICHR EPS (Earnings per Share)

EPS (Earnings per Share) of ICHR over the last years for every Quarter: "2020-09": 0.62, "2020-12": 0.81, "2021-03": 0.76, "2021-06": 0.9, "2021-09": 0.81, "2021-12": 0.9, "2022-03": 0.7, "2022-06": 0.98, "2022-09": 1.22, "2022-12": 0.72, "2023-03": 0.38, "2023-06": 0.02, "2023-09": 0.07, "2023-12": -0.06, "2024-03": -0.09, "2024-06": 0.05, "2024-09": 0.12, "2024-12": 0.08, "2025-03": 0.12, "2025-06": 0.03, "2025-09": 0,

ICHR Revenue

Revenue of ICHR over the last years for every Quarter: 2020-09: 227.678, 2020-12: 244.966, 2021-03: 264.566, 2021-06: 282.308, 2021-09: 262.855, 2021-12: 287.188, 2022-03: 293.146, 2022-06: 329.56, 2022-09: 355.643, 2022-12: 301.72, 2023-03: 225.87, 2023-06: 185.008, 2023-09: 196.761, 2023-12: 203.481, 2024-03: 201.383, 2024-06: 203.227, 2024-09: 211.139, 2024-12: 233.291, 2025-03: 244.465, 2025-06: 240.285, 2025-09: null,

Description: ICHR Ichor Holdings October 23, 2025

Ichor Holdings Ltd (NASDAQ:ICHR) designs, engineers, and manufactures fluid-delivery subsystems and precision components for semiconductor capital equipment. Its product portfolio includes gas delivery modules that regulate etch and deposition gases, and chemical delivery systems that blend reactive liquids for processes such as chemical-mechanical planarization, electroplating, and wafer cleaning. The company also produces specialty parts-weldments, electron-beam and laser-welded components, vacuum-brazed assemblies, and surface-treatment technologies-primarily sold to equipment OEMs, with Japan representing its largest market exposure. Ichor was founded in 1999 and is headquartered in Fremont, California.

Recent data (FY 2023) show Ichor generated approximately $155 million in revenue, with a gross margin of ~38% and a modest operating margin of 4.5%, reflecting the capital-intensive nature of its niche. The semiconductor equipment market is being driven by sustained demand for AI-optimized chips and advanced packaging, which together are projected to grow at a 9-12% CAGR through 2028 (source: SEMI). Ichor’s exposure to gas-delivery systems aligns with the rising share of high-k/metal-gate and EUV-based nodes, where precise gas control is a critical cost driver for fab operators.

For a deeper quantitative view of ICHR’s valuation and peer benchmarks, the ValueRay platform provides a granular breakdown of forward earnings multiples, cash-flow projections, and scenario-based sensitivity analyses.

ICHR Stock Overview

Market Cap in USD 779m
Sub-Industry Semiconductor Materials & Equipment
IPO / Inception 2016-12-09

ICHR Stock Ratings

Growth Rating -76.0%
Fundamental 32.6%
Dividend Rating -
Return 12m vs S&P 500 -61.2%
Analyst Rating 4.43 of 5

ICHR Dividends

Currently no dividends paid

ICHR Growth Ratios

Growth Correlation 3m 41.5%
Growth Correlation 12m -72.6%
Growth Correlation 5y -60.3%
CAGR 5y -20.31%
CAGR/Max DD 3y (Calmar Ratio) -0.29
CAGR/Mean DD 3y (Pain Ratio) -0.73
Sharpe Ratio 12m -0.73
Alpha -82.12
Beta 1.876
Volatility 126.35%
Current Volume 1354.1k
Average Volume 20d 797.3k
Stop Loss 13.9 (-7.1%)
Signal -1.36

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (-20.7m TTM) > 0 and > 6% of Revenue (6% = 55.8m TTM)
FCFTA -0.02 (>2.0%) and ΔFCFTA -7.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 32.58% (prev 39.82%; Δ -7.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.02 (>3.0%) and CFO 17.1m > Net Income -20.7m (YES >=105%, WARN >=100%)
Net Debt (-42.9m) to EBITDA (16.6m) ratio: -2.59 <= 3.0 (WARN <= 3.5)
Current Ratio 3.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (34.2m) change vs 12m ago 1.88% (target <= -2.0% for YES)
Gross Margin 11.89% (prev 11.55%; Δ 0.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 96.15% (prev 84.93%; Δ 11.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -2.52 (EBITDA TTM 16.6m / Interest Expense TTM 6.59m) >= 6 (WARN >= 3)

Altman Z'' 3.08

(A) 0.31 = (Total Current Assets 439.1m - Total Current Liabilities 136.4m) / Total Assets 985.1m
(B) 0.17 = Retained Earnings (Balance) 169.9m / Total Assets 985.1m
(C) -0.02 = EBIT TTM -16.6m / Avg Total Assets 966.4m
(D) 0.58 = Book Value of Equity 169.9m / Total Liabilities 290.9m
Total Rating: 3.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 32.63

1. Piotroski 3.0pt = -2.0
2. FCF Yield -2.59% = -1.29
3. FCF Margin -2.05% = -0.77
4. Debt/Equity 0.07 = 2.50
5. Debt/Ebitda -2.59 = 2.50
6. ROIC - WACC (= -15.28)% = -12.50
7. RoE -2.97% = -0.49
8. Rev. Trend -34.74% = -2.61
9. EPS Trend -54.22% = -2.71

What is the price of ICHR shares?

As of November 09, 2025, the stock is trading at USD 14.97 with a total of 1,354,096 shares traded.
Over the past week, the price has changed by -33.99%, over one month by -20.07%, over three months by -10.14% and over the past year by -55.75%.

Is Ichor Holdings a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Ichor Holdings (NASDAQ:ICHR) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 32.63 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ICHR is around 10.65 USD . This means that ICHR is currently overvalued and has a potential downside of -28.86%.

Is ICHR a buy, sell or hold?

Ichor Holdings has received a consensus analysts rating of 4.43. Therefore, it is recommended to buy ICHR.
  • Strong Buy: 5
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ICHR price?

Issuer Target Up/Down from current
Wallstreet Target Price 24.8 65.9%
Analysts Target Price 24.8 65.9%
ValueRay Target Price 12.3 -17.8%

ICHR Fundamental Data Overview November 04, 2025

Market Cap USD = 778.5m (778.5m USD * 1.0 USD.USD)
P/E Forward = 35.7143
P/S = 0.8379
P/B = 1.0143
P/EG = 0.5096
Beta = 1.876
Revenue TTM = 929.2m USD
EBIT TTM = -16.6m USD
EBITDA TTM = 16.6m USD
Long Term Debt = 117.5m USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 49.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -42.9m USD (from netDebt column, last quarter)
Enterprise Value = 735.6m USD (778.5m + Debt 49.3m - CCE 92.2m)
Interest Coverage Ratio = -2.52 (Ebit TTM -16.6m / Interest Expense TTM 6.59m)
FCF Yield = -2.59% (FCF TTM -19.0m / Enterprise Value 735.6m)
FCF Margin = -2.05% (FCF TTM -19.0m / Revenue TTM 929.2m)
Net Margin = -2.23% (Net Income TTM -20.7m / Revenue TTM 929.2m)
Gross Margin = 11.89% ((Revenue TTM 929.2m - Cost of Revenue TTM 818.7m) / Revenue TTM)
Gross Margin QoQ = 11.32% (prev 11.67%)
Tobins Q-Ratio = 0.75 (Enterprise Value 735.6m / Total Assets 985.1m)
Interest Expense / Debt = 3.32% (Interest Expense 1.64m / Debt 49.3m)
Taxrate = -41.09% (negative due to tax credits) (2.74m / -6.67m)
NOPAT = -23.4m (EBIT -16.6m * (1 - -41.09%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 3.22 (Total Current Assets 439.1m / Total Current Liabilities 136.4m)
Debt / Equity = 0.07 (Debt 49.3m / totalStockholderEquity, last quarter 694.1m)
Debt / EBITDA = -2.59 (Net Debt -42.9m / EBITDA 16.6m)
Debt / FCF = 2.26 (negative FCF - burning cash) (Net Debt -42.9m / FCF TTM -19.0m)
Total Stockholder Equity = 697.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.10% (Net Income -20.7m / Total Assets 985.1m)
RoE = -2.97% (Net Income TTM -20.7m / Total Stockholder Equity 697.5m)
RoCE = -2.04% (EBIT -16.6m / Capital Employed (Equity 697.5m + L.T.Debt 117.5m))
RoIC = -2.84% (negative operating profit) (NOPAT -23.4m / Invested Capital 825.2m)
WACC = 12.44% (E(778.5m)/V(827.8m) * Re(12.93%) + D(49.3m)/V(827.8m) * Rd(3.32%) * (1-Tc(-0.41)))
Discount Rate = 12.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.81%
Fair Price DCF = unknown (Cash Flow -19.0m)
EPS Correlation: -54.22 | EPS CAGR: -53.85% | SUE: -1.51 | # QB: 0
Revenue Correlation: -34.74 | Revenue CAGR: -13.29% | SUE: 1.97 | # QB: 1

Additional Sources for ICHR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle